Triptorelin

Generic Name
Triptorelin
Brand Names
Decapeptyl, Trelstar, Triptodur
Drug Type
Small Molecule
Chemical Formula
C64H82N18O13
CAS Number
57773-63-4
Unique Ingredient Identifier
9081Y98W2V
Background

Triptorelin is a synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. S...

Indication

Triptorelin is indicated for the palliative treatment of advanced prostate cancer.

Associated Conditions
Advanced Prostate Cancer
Associated Therapies
Controlled ovarian hyperstimulation therapy

Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI

First Posted Date
2017-04-18
Last Posted Date
2017-11-07
Lead Sponsor
Cairo University
Target Recruit Count
204
Registration Number
NCT03118830
Locations
🇪🇬

Ahmed Maged, Cairo, Egypt

Luteal Phase Support in Insemination Cycles

Phase 4
Completed
Conditions
Interventions
First Posted Date
2017-04-14
Last Posted Date
2020-01-27
Lead Sponsor
Tampere University Hospital
Target Recruit Count
167
Registration Number
NCT03115307
Locations
🇫🇮

Tampere University Hospital, Tampere, Finland

Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

Not Applicable
Conditions
Interventions
First Posted Date
2016-07-11
Last Posted Date
2016-07-12
Lead Sponsor
Meir Medical Center
Target Recruit Count
50
Registration Number
NCT02827656

Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study

First Posted Date
2016-07-07
Last Posted Date
2016-12-13
Lead Sponsor
Sheba Medical Center
Target Recruit Count
62
Registration Number
NCT02825290
Locations
🇮🇱

Sheba medical center, Ramat Gan, Israel

Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2016-04-25
Last Posted Date
2016-04-25
Lead Sponsor
Pharmatech
Target Recruit Count
41
Registration Number
NCT02749825
Locations
🇺🇸

Jazrawi-Atallah, P.C., Brooklyn, New York, United States

🇺🇸

Albemarle Urology Clinic, PA, Albemarle, North Carolina, United States

🇺🇸

Raj P. Chopra MD, PC, Bloomsburg, Pennsylvania, United States

and more 8 locations

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

First Posted Date
2016-04-19
Last Posted Date
2020-07-07
Lead Sponsor
Fudan University
Target Recruit Count
200
Registration Number
NCT02742675
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Effects of Sex Steroids on the Serotonin System

First Posted Date
2016-03-22
Last Posted Date
2018-10-15
Lead Sponsor
Medical University of Vienna
Target Recruit Count
92
Registration Number
NCT02715232
Locations
🇦🇹

Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria

Management of Castration-Resistant Prostate Cancer with Oligometastases

First Posted Date
2016-02-18
Last Posted Date
2024-12-04
Lead Sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Target Recruit Count
102
Registration Number
NCT02685397
Locations
🇨🇦

BC CANCER Vancouver, Vancouver, British Columbia, Canada

🇨🇦

CancerCare Manitoba, Winnipeg, Manitoba, Canada

🇨🇦

Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada

and more 8 locations

Miniflare Versus Long Protocol in Poor Responders

First Posted Date
2016-02-12
Last Posted Date
2016-04-04
Lead Sponsor
Woman's Health University Hospital, Egypt
Target Recruit Count
200
Registration Number
NCT02681536
Locations
🇪🇬

Kasr el aini hospital, Cairo, Egypt

Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol

First Posted Date
2015-12-21
Last Posted Date
2015-12-21
Lead Sponsor
Chong Qing Reproducive and Genetic Institute
Target Recruit Count
200
Registration Number
NCT02635607
© Copyright 2024. All Rights Reserved by MedPath